Abstract:Background Resting heart rate (HR) is a strong established marker of risk in patients with heart failure (HF), but the clinical implications of changes in HR over time are less well established. We aimed to explore the association between visit-to-visit changes in HR and cardiovascular (CV) outcomes in a pooled participant-level dataset of 2 large cohorts of patients with HF across the full range of left ventricular ejection fraction (LVEF). Methods PARADIGM-HF and PARAGON-HF were global, multicenter, randomized clinical trials testing sacubitril/valsartan against an active control (enalapril or valsartan, respectively) in patients with HF and LVEF ≤40% (in PARADIGM-HF) or LVEF ≥45% (in PARAGON-HF). Change in HR was defined as the difference in HR between a visit at any time and the preceding visit. The association between the change in HR and subsequent risk of first HF hospitalization (HFH) or CV death was assessed using Cox proportional hazards models, after adjusting for HR at the preceding visit and potential confounders. HR at any time was also assessed using repeated measures regression models with restricted cubic splines, and was plotted relative to time defined as the number of months prior to or immediately following a HFH event or end of follow-up. Patients who experienced HFH during the study period were compared to a control population who remained free of all-cause hospitalization and all-cause death during the follow-up period. Results A total of 13,194 patients (mean age 67±11 years, 67% men, mean LVEF 40±15%) were included. Heart rates were available in 16 visits in both PARADIGM-HF and PARAGON-HF. Over a median follow-up of 2.4 years, 3,114 patients underwent a first HFH or CV death (10.4 events per 100 patient-years). Any increase in HR from the preceding visit, compared with no change, was associated with a significantly higher risk of first HFH or CV death (Figure 1, adjusted hazard ratio 1.10, 95% confidence interval, CI: 1.08–1.13, P<0.001, per 5 bpm increase in HR). Conversely, a drop in HR was associated with significantly lower risk. This prognostic association between temporal changes of HR and risk of first HFH or CV death was consistent across the range of LVEF (Pinteraction=0.34) and seen irrespective of background use of β-blockers (Pinteraction=0.91). Relative increases in HR were especially prognostic in patients without a history of atrial fibrillation/flutter (Pinteraction=0.01). HR at any time appeared to increase during the 8 months prior to a HFH event, and remained elevated after hospitalization, in comparison to a relatively stable HR observed in the control group (Figure 2). Conclusions Across a broad spectrum of patients with chronic HF, relative increases in HR from a preceding visit strongly and independently predicted both CV and non-CV outcomes. Our findings suggest that detection of notable increases in HR between outpatient visits may help identify patients at heightened risk of adverse events.

Association between admission heart rate and major adverse cardiovascular events in acute myocardial infarction participants with different left ventricular ejection fraction

First-phase Ejection Fraction to Predict Adverse Outcomes in Patients with Heart Failure.

Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction

Clinical significance and related factors of admission heart rate in patients with acute coro-nary syndrome

Association Between Heart Rate and Major Adverse Cardiovascular Events among 9,991 Hypertentive Patients: A Multicenter Retrospective Follow-Up Study.

Effects of Hemoglobin Levels on Long-Term Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

The relationship between admission heart rate and cardiovascular risk factors in subjects with acute myocardial infarction

Survival Predictors of Heart Rate Variability After Myocardial Infarction With and Without Low Left Ventricular Ejection Fraction

Blood Urea Nitrogen to Left Ventricular Ejection Ratio as a Predictor of Short-Term Outcome in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Association of Ejection Fraction with Mortality and Cardiovascular Events in Patients with Coronary Artery Disease

Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study

The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction

Assessment of the impact of resting heart rate on the risk of major adverse cardiovascular events after ischemic stroke: a retrospective observational study

Insight into the relationship between heart rate and mortality in patients in sinus rhythm with heart failure with preserved ejection fraction

Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction

Predicting efficacy of combined assessment with fragmented QRS and severely depressed heart rate variability on outcome of patients with acute myocardial infarction

E0430 Highsensitivity Creactive Protein Levels at Admission Can Not Be Used to Predict Inhospital Mortality in Patients with Acute Myocardial Infarction a Retrospective Study

Impaired Coronary Flow Reserve in Patients with Supra-Normal Left Ventricular Ejection Fraction at Rest

Visit-to-visit changes in heart rate in heart failure: a pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials

Association of monocyte to HDL cholesterol ratio and a composite risk score with left ventricular aneurysm formation in patients with acute ST-segment elevation myocardial infarction

Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction